arrow
R

Roberta Gagliardini

national institute for infectious diseases lazzaro spallanzani- irccs
H指数:29
被引数:2,653

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Ion Torrent Genexus as a Fast and Reliable Solution for HIV-1 Drug Resistance Testing: Comparison with the GeneStudio S5 Workflow

Ion Torrent Genexus作为HIV-1药物耐药性检测的快速可靠解决方案:与GeneStudio S5工作流的比较

2026-07-230
OA
Virological outcomes of PWH who discontinued cabotegravir/rilpivirine long-acting therapy in a real-world context

HIV感染者中停用卡博特韦/利匹韦林长效疗法后的病毒学结局

2026-04-150
OAAI
Improved HIV-1 Subtyping Accuracy Using near Full-Length Sequencing: A Comparison of Common Tools

使用近全长测序提高HIV-1分型准确性:常用工具的比较

2025-12-020
OAAI
Durability of lenacapavir in viremic heavily treatment-experienced people with HIV: real-world data from the PRESTIGIO Registry

lenacapavir在病毒血症且治疗经验丰富的HIV感染者中的持久性:PRESTIGIO登记研究中的真实世界数据

2025-11-010
PRE
Long-term trajectories of Hepatic and Metabolic biomarkers after switching from TDF to TAF in ART-Experienced PWH with and without Hepatic Coinfection: Data from the ICONA Cohort

从TDF转换为TAF后,在伴有和不伴有肝共感染的经治人类免疫缺陷病毒感染者中,肝脏和代谢生物标志物的长期变化轨迹:ICONA队列研究数据

2025-10-040
OAAI
Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry

评估高治疗经验且多重耐药个体在抑制性抗逆转录病毒治疗下HIV-1 DNA耐药性演化的纵向研究:PRESTIGIO登记研究

2025-09-010
OAAI
All-cause and Cause-specific Mortality in People With HIV in Italy in 1997-2022: Data From the Icona Cohort

1997-2022年意大利HIV感染者全因和特定原因死亡率:Icona队列研究数据

2025-08-010
OAAI
Investigation of Natural Resistance to Fostemsavir and Lenacapavir in Naïve Primary Infections by Ultra-Deep Sequencing of near Full-Length HIV-1 Genomes

通过超深度测序近全长HIV-1基因组对初治原发性感染中福司特沙韦和伦卡帕韦的自然耐药性进行调查

2025-04-280
OA
Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or mRNA XBB.1.5 SARS-CoV-2 Booster Vaccine

HIV感染者接种基于蛋白或mRNA XBB.1.5 SARS-CoV-2加强疫苗后对近期奥密克戎亚系的免疫应答

2025-04-090
OA
Reactogenicity and Immunogenicity Against MPXV of the Intradermal Administration of Modified Vaccinia Ankara Compared to the Standard Subcutaneous Route
2024-12-310
OAAI
Impact of switching from efavirenz/emtricitabine/tenofovir disoproxil fumarate to bictegravir/emtricitabine/tenofovir alafenamide on psychiatric symptoms and neurocognition
AIDS
IF3.1
2024-10-240
PRE
HIV-1 transmitted drug resistance in newly diagnosed individuals in Italy over the period 2015-21
2024-07-192
OAAI